155 related articles for article (PubMed ID: 8748944)
1. Comparative studies on differential inhibition of the renin - angiotensin system in the anesthetized guinea pig.
Duan J; Jaramillo J; Jung GL; McLeod AL; Fernandes BH; Mathis D
Can J Physiol Pharmacol; 1995 Oct; 73(10):1512-8. PubMed ID: 8748944
[TBL] [Abstract][Full Text] [Related]
2. Effects of renin-angiotensin system blockade in guinea pigs.
Véniant M; Clozel JP; Hess P; Fischli W
Hypertension; 1992 Mar; 19(3):255-62. PubMed ID: 1532164
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure.
Morton JJ; Beattie EC; MacPherson F
J Vasc Res; 1992; 29(3):264-9. PubMed ID: 1387008
[TBL] [Abstract][Full Text] [Related]
5. Relation between inhibition of renal angiotensin II production and hemodynamic effect of captopril in anesthetized rabbit.
Li T; Zimmerman BG
J Hypertens; 1992 Aug; 10(8):795-805. PubMed ID: 1325512
[TBL] [Abstract][Full Text] [Related]
6. Nonpeptide angiotensin II receptor antagonists. Studies with DuP 753 and EXP3174 in dogs.
Wong PC; Hart SD; Duncia JV; Timmermans PB
Eur J Pharmacol; 1991 Sep; 202(3):323-30. PubMed ID: 1748155
[TBL] [Abstract][Full Text] [Related]
7. Kinin contribution to renal vasodilator effect of captopril in rabbit.
Hajj-ali AF; Zimmerman BG
Hypertension; 1991 Apr; 17(4):504-9. PubMed ID: 1849501
[TBL] [Abstract][Full Text] [Related]
8. Effects of the angiotensin II receptor antagonist Losartan (DuP 753/MK 954) on arterial blood pressure, heart rate, plasma concentrations of angiotensin II and renin and the pressor response to infused angiotensin II in the salt-deplete dog.
MacFadyen RJ; Tree M; Lever AF; Reid JL
Clin Sci (Lond); 1992 Nov; 83(5):549-56. PubMed ID: 1335390
[TBL] [Abstract][Full Text] [Related]
9. Non-peptide angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor: effect on a renin-induced deficit of a passive avoidance response in rats.
DeNoble VJ; DeNoble KF; Spencer KR; Chiu AT; Wong PC; Timmermans PB
Brain Res; 1991 Oct; 561(2):230-5. PubMed ID: 1802340
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of losartan (DuP 753)-induced angiotensin II receptor antagonism by PD123177 in rats.
Wong PC; Christ DD; Timmermans PB
Eur J Pharmacol; 1992 Sep; 220(2-3):267-70. PubMed ID: 1425998
[TBL] [Abstract][Full Text] [Related]
11. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system.
Säynävälammi P; Pörsti I
Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510
[TBL] [Abstract][Full Text] [Related]
13. Role of endogenous bradykinins in the acute depressor effect of angiotensin converting enzyme inhibitor captopril--assessed by a competitive antagonist of bradykinin.
Seino M; Abe K; Nushiro N; Omata K; Yoshinaga K
Clin Exp Hypertens A; 1989; 11(1):35-43. PubMed ID: 2653669
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the effects of renin inhibition and angiotensin converting enzyme inhibition upon bradykinin potentiation.
Véniant M; Clozel JP; Fischli W
J Hypertens; 1992 Feb; 10(2):155-60. PubMed ID: 1313478
[TBL] [Abstract][Full Text] [Related]
15. Converting enzyme inhibition in mild and moderate essential hypertension. I. Acute effects on blood pressure, the renin-angiotensin system and blood bradykinin after a single dose of captopril.
Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J
Acta Med Scand; 1985; 218(5):435-42. PubMed ID: 3004113
[TBL] [Abstract][Full Text] [Related]
16. [Angiotensin converting enzyme inhibitory activity of MK-0521 in vivo and antihypertensive effect of its single oral administration on blood pressure and effect on the renin-angiotensin system in 2-kidney Goldblatt hypertensive dogs].
Oda M; Ino Y; Suzuki K; Sato T; Iwamoto S; Iwaki M
Nihon Yakurigaku Zasshi; 1989 Apr; 93(4):225-34. PubMed ID: 2545579
[TBL] [Abstract][Full Text] [Related]
17. Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.
Fenoy FJ; Scicli G; Carretero O; Roman RJ
Hypertension; 1991 Jun; 17(6 Pt 2):1038-44. PubMed ID: 1646165
[TBL] [Abstract][Full Text] [Related]
18. The haemodynamic effects of two angiotensin converting enzyme inhibitors, enalaprilat and zofenoprilat, in the rat: evidence for the involvement of bradykinin.
Tio RA; Heiligers JP; de Langen CD; van Gilst WH; König W; Saxena PR; Wesseling H
J Hypertens Suppl; 1989 Dec; 7(6):S296-7. PubMed ID: 2561143
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effect of renin inhibition and angiotensin-converting enzyme inhibition in ovine heart failure.
Fitzpatrick MA; Rademaker MT; Charles CJ; Yandle TG; Espiner EA; Ikram H; Nussberger J
J Cardiovasc Pharmacol; 1992 Feb; 19(2):169-75. PubMed ID: 1376784
[TBL] [Abstract][Full Text] [Related]
20. Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats.
Bader M; Zhao Y; Sander M; Lee MA; Bachmann J; Böhm M; Djavidani B; Peters J; Mullins JJ; Ganten D
Hypertension; 1992 Jun; 19(6 Pt 2):681-6. PubMed ID: 1592468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
